Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

2.46
Delayed Data
As of Jun 22
 0.00 / 0.00%
Today’s Change
1.93
Today|||52-Week Range
3.77
+16.04%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
AssetsCash221.8M96.6M147.2M314.3M
 
 
 
 
 
Short Term Investment Cash-68.9M-115.2M40.6M167.2M
 
 
 
 
 
Cash & Short Term Investments221.8M189.6M242.1M409.3M
 
 
 
 
 
 
ReceivablesReceivables98.2M162.9M151.3M125.3M
 
 
 
 
 
 
InventoriesInventories0.001.6M2.9M3.5M
 
 
 
 
 
Current AssetsOther Current Assets673.0K973.0K1.7M5.9M
 
 
 
 
 
Current Assets320.7M355.1M398.0M544.0M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross----9.2M--
 
 
Depreciation-----9.2M--
 
 
Intangible Assets339.3M637.9M630.9M516.3M
 
 
 
 
 
Other Assets350.9M646.9M638.3M523.8M
 
 
 
 
 
Total Assets1.0B1.2B1.2B1.2B
 
 
 
 
 
 
LiabilitiesAccounts Payable1.1M7.1M7.0M18.0M
 
 
 
 
 
Short Term Debt0.000.000.00122.7M
 
 
Accrued Expenses6.6M2.9M24.9M30.2M
 
 
 
 
 
Other Current Liabilities7.7M103.7M115.4M121.0M
 
 
 
 
 
Other Liabilities22.6M121.5M130.3M275.3M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt232.8M234.9M232.4M112.4M
 
 
 
 
 
Deferred Taxes-25.7M-24.2M-19.3M-11.7M
 
 
 
 
 
Other Liabilities13.9M14.8M13.0M13.6M
 
 
 
 
 
Total Liabilities310.5M462.2M460.0M474.8M
 
 
 
 
 
 
EquityMinority Interest0.00-3.0K-56.0K-47.0K
 
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity738.7M749.6M751.1M758.7M
 
 
 
 
 
Total Shareholder Equity738.7M749.6M751.1M758.7M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding165.5M165.5M165.5M163.7M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.